Index RUT P/E - EPS (ttm) - Insider Own 51.41% Shs Outstand 33.38M Perf Week -27.76%
Market Cap 330.50M Forward P/E - EPS next Y - Insider Trans 97.93% Shs Float 16.24M Perf Month -48.33%
Income - PEG - EPS next Q -0.56 Inst Own 42.13% Short Float 10.31% Perf Quarter -59.12%
Sales - P/S - EPS this Y - Inst Trans 30.35% Short Ratio 8.02 Perf Half Y -
Book/sh 8.13 P/B 1.22 EPS next Y - ROA - Short Interest 1.67M Perf Year -
Cash/sh 8.29 P/C 1.19 EPS next 5Y - ROE - 52W Range 9.65 - 27.50 Perf YTD -46.34%
Dividend Est. - P/FCF - EPS past 5Y - ROI - 52W High -64.04% Beta -
Dividend TTM - Quick Ratio 25.75 Sales past 5Y 0.00% Gross Margin - 52W Low 2.49% ATR (14) 1.93
Dividend Ex-Date - Current Ratio 25.75 EPS Y/Y TTM - Oper. Margin - RSI (14) 21.80 Volatility 13.15% 11.60%
Employees - Debt/Eq 0.00 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 39.67
Option/Short No / Yes LT Debt/Eq 0.00 EPS Q/Q -138.42% Payout - Rel Volume 1.08 Prev Close 10.54
Sales Surprise - EPS Surprise -2.33% Sales Q/Q - Earnings Nov 07 BMO Avg Volume 208.78K Price 9.89
SMA20 -40.65% SMA50 -47.32% SMA200 -51.97% Trades
Volume 225,160 Change -6.17%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-08-24 Initiated Stifel
Buy
$40
Oct-08-24 Initiated JP Morgan
Overweight
$30
Oct-08-24 Initiated Jefferies
Buy
$35
Oct-08-24 Initiated Guggenheim
Buy
$44
Jan-07-25 11:47AM
07:00AM
Dec-18-24 08:00AM
Dec-02-24 08:00AM
Nov-18-24 08:00AM
08:00AM
Loading…
Nov-07-24 08:00AM
Oct-28-24 08:00AM
Oct-14-24 06:45AM
Sep-30-24 08:00AM
Sep-23-24 07:05PM
Sep-18-24 03:19AM
Sep-16-24 04:05PM
Sep-12-24 07:11PM
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mathers Edward T Director Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:28 PM BASKETT FOREST 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:26 PM Behbahani Ali 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:24 PM Chang Carmen 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:23 PM Florence Anthony A. Jr. 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:21 PM Makhzoumi Mohamad 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:20 PM Walker Paul Edward 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:18 PM Yang Rick 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:17 PM SANDELL SCOTT D 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:14 PM ORBIMED ADVISORS LLC Director Sep 16 '24 Buy 16.00 750,000 12,000,000 3,158,428 Sep 17 08:13 PM New Enterprise Associates 17, 10% Owner Sep 16 '24 Buy 16.00 500,000 8,000,000 3,614,486 Sep 17 08:12 PM Frazier Life Sciences X, L.P. 10% Owner Sep 16 '24 Buy 16.00 625,000 10,000,000 4,552,774 Sep 17 08:11 PM Heron Patrick J Director Sep 16 '24 Buy 16.00 625,000 10,000,000 4,552,774 Sep 17 08:09 PM Aynechi Tiba Director Sep 16 '24 Buy 16.00 750,000 12,000,000 2,136,335 Sep 17 08:05 PM GORDON CARL L Director Sep 16 '24 Buy 16.00 750,000 12,000,000 3,158,428 Sep 17 08:05 PM
Index RUT P/E - EPS (ttm) -12.02 Insider Own 40.57% Shs Outstand 9.32M Perf Week 4.93%
Market Cap 346.63M Forward P/E - EPS next Y -9.74 Insider Trans -0.29% Shs Float 5.57M Perf Month -23.17%
Income -101.60M PEG - EPS next Q -2.50 Inst Own 59.09% Short Float 11.74% Perf Quarter -51.95%
Sales 0.00M P/S - EPS this Y 82.58% Inst Trans 11.14% Short Ratio 5.13 Perf Half Y -21.24%
Book/sh 19.28 P/B 1.92 EPS next Y -5.31% ROA -70.10% Short Interest 0.65M Perf Year -15.20%
Cash/sh 14.81 P/C 2.50 EPS next 5Y - ROE -93.91% 52W Range 30.00 - 98.00 Perf YTD -2.81%
Dividend Est. - P/FCF - EPS past 5Y -11.67% ROI -45.89% 52W High -62.24% Beta 3.72
Dividend TTM - Quick Ratio 11.23 Sales past 5Y -33.55% Gross Margin - 52W Low 23.31% ATR (14) 3.85
Dividend Ex-Date - Current Ratio 11.23 EPS Y/Y TTM 85.54% Oper. Margin - RSI (14) 39.90 Volatility 6.49% 8.75%
Employees 101 Debt/Eq 0.23 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 136.86
Option/Short No / Yes LT Debt/Eq 0.23 EPS Q/Q 85.65% Payout - Rel Volume 0.45 Prev Close 36.98
Sales Surprise - EPS Surprise 10.56% Sales Q/Q - Earnings Nov 12 AMC Avg Volume 127.59K Price 37.00
SMA20 -7.29% SMA50 -21.92% SMA200 -23.82% Trades
Volume 58,032 Change 0.05%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-10-25 Initiated Oppenheimer
Outperform
$155
Oct-21-24 Initiated Raymond James
Strong Buy
$153
Aug-14-24 Initiated William Blair
Outperform
$180
Mar-28-24 Reiterated H.C. Wainwright
Buy
$100 → $115
Feb-27-24 Initiated BMO Capital Markets
Outperform
$120
Dec-04-23 Initiated H.C. Wainwright
Buy
$100
Nov-29-23 Initiated RBC Capital Mkts
Outperform
$70
Nov-10-23 Initiated Piper Sandler
Overweight
$180
Feb-15-23 Downgrade Chardan Capital Markets
Buy → Neutral
Feb-13-23 Downgrade Cowen
Outperform → Market Perform
Sep-22-21 Downgrade Goldman
Buy → Neutral
$12 → $9
Jan-27-21 Upgrade JP Morgan
Neutral → Overweight
$56
Dec-22-20 Initiated B. Riley Securities
Buy
$79
Jul-14-20 Initiated Oppenheimer
Outperform
$36
May-18-20 Downgrade JP Morgan
Overweight → Neutral
$27
Oct-28-19 Initiated JP Morgan
Overweight
$25
Oct-28-19 Initiated Goldman
Buy
$30
Oct-28-19 Initiated Cowen
Outperform
Show Previous Ratings
Jan-13-25 08:00AM
Jan-07-25 08:00AM
Dec-10-24 08:00AM
Nov-21-24 04:01PM
07:30AM
08:00AM
Loading…
Nov-14-24 08:00AM
Nov-12-24 04:05PM
(GlobeNewswire) -11.37%
-15.55%
Nov-04-24 07:25AM
Oct-21-24 04:15PM
(Investor's Business Daily) -5.22%
-7.70%
Oct-16-24 04:20PM
(Investor's Business Daily) +93.66%
Sep-30-24 08:00AM
Sep-16-24 08:00AM
Sep-10-24 08:00AM
Aug-28-24 08:00AM
Aug-27-24 08:00AM
04:01PM
Loading…
Aug-13-24 04:01PM
Jul-01-24 08:00AM
Jun-25-24 12:53PM
May-30-24 04:01PM
May-20-24 02:30PM
May-14-24 10:55PM
04:01PM
Apr-18-24 08:30AM
Apr-01-24 04:01PM
Mar-26-24 04:01PM
Feb-27-24 09:55AM
08:00AM
Feb-09-24 09:55AM
Jan-18-24 08:00AM
Jan-04-24 08:00AM
08:00AM
Loading…
Dec-07-23 08:00AM
Nov-28-23 08:00AM
Nov-03-23 03:31PM
12:19PM
Aug-10-23 04:01PM
Jul-17-23 11:59AM
Jul-14-23 11:22AM
06:30AM
May-12-23 04:01PM
Mar-10-23 07:30AM
Feb-27-23 07:30AM
Feb-13-23 01:55PM
(American City Business Journals) -80.54%
11:17AM
08:05AM
Dec-19-22 07:30AM
Dec-15-22 07:30AM
Nov-17-22 07:30AM
Nov-08-22 04:05PM
Oct-12-22 07:30AM
Aug-30-22 07:30AM
Aug-09-22 04:05PM
(Business Wire) -11.11%
+9.00%
Jun-24-22 09:03AM
May-25-22 12:00PM
May-18-22 07:30AM
May-04-22 04:30PM
Apr-22-22 07:30AM
Apr-08-22 05:00PM
Mar-15-22 07:30AM
Mar-10-22 06:35PM
Feb-28-22 07:30AM
Jan-14-22 05:43AM
Jan-04-22 07:30AM
Dec-28-21 02:38AM
Dec-09-21 01:18PM
07:30AM
Nov-30-21 05:53AM
Nov-15-21 12:25PM
07:30AM
Nov-09-21 07:30AM
Nov-08-21 03:00PM
Oct-27-21 07:30AM
Oct-21-21 07:30AM
Oct-01-21 08:23AM
Sep-22-21 11:18AM
07:30AM
Sep-08-21 07:30AM
Aug-30-21 05:10PM
Aug-12-21 04:06PM
08:45AM
07:30AM
Aug-04-21 03:00PM
Aug-02-21 03:05PM
02:30PM
12:30PM
12:30PM
11:00AM
10:00AM
09:16AM
09:09AM
05:50AM
03:27AM
Aug-01-21 10:38AM
06:36AM
Jul-30-21 08:49PM
07:19PM
07:10PM
05:15PM
02:57PM
01:30PM
12:40PM
Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Agarwal Vineet Chief Financial Officer Nov 11 '24 Option Exercise 11.68 800 9,344 800 Nov 12 07:40 PM Agarwal Vineet Chief Financial Officer Nov 11 '24 Sale 70.00 800 56,000 0 Nov 12 07:40 PM Agarwal Vineet Officer Nov 11 '24 Proposed Sale 70.00 800 56,000 Nov 12 08:28 AM Agarwal Vineet Chief Financial Officer Oct 17 '24 Option Exercise 11.99 10,216 122,468 10,216 Oct 18 07:43 PM Agarwal Vineet Chief Financial Officer Oct 17 '24 Sale 78.26 10,216 799,527 0 Oct 18 07:43 PM Agarwal Vineet Officer Oct 17 '24 Proposed Sale 78.26 10,216 799,527 Oct 17 04:22 PM Colletti Steve Former Officer Oct 16 '24 Proposed Sale 88.67 13,821 1,225,450 Oct 16 01:05 PM Colletti Steve Former Officer Aug 30 '24 Proposed Sale 49.24 10,303 507,326 Aug 30 05:28 PM New Enterprise Associates 17, 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM BASKETT FOREST 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Florence Anthony A. Jr. 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Walker Paul Edward 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Chang Carmen 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Mathers Edward T 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Yang Rick 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Makhzoumi Mohamad 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM SANDELL SCOTT D 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 1,090,793 Apr 24 05:00 PM Atlas Venture Opportunity Fund 10% Owner Apr 22 '24 Buy 56.00 17,857 999,992 195,074 Apr 23 05:23 PM
Index - P/E - EPS (ttm) -0.28 Insider Own 12.48% Shs Outstand 305.39M Perf Week 4.03%
Market Cap 40.21B Forward P/E 140.91 EPS next Y 0.83 Insider Trans -3.65% Shs Float 300.37M Perf Month 2.19%
Income -93.82M PEG - EPS next Q 0.18 Inst Own 75.75% Short Float 2.72% Perf Quarter 28.27%
Sales 1.57B P/S 25.58 EPS this Y 51.58% Inst Trans 0.18% Short Ratio 2.98 Perf Half Y 49.21%
Book/sh 2.84 P/B 41.30 EPS next Y 11.95% ROA -3.32% Short Interest 8.17M Perf Year 52.02%
Cash/sh 5.32 P/C 22.03 EPS next 5Y 52.22% ROE -11.22% 52W Range 66.24 - 119.42 Perf YTD 8.80%
Dividend Est. - P/FCF 236.69 EPS past 5Y -13.56% ROI -3.94% 52W High -1.89% Beta 1.10
Dividend TTM - Quick Ratio 3.37 Sales past 5Y 46.00% Gross Margin 77.49% 52W Low 76.87% ATR (14) 4.17
Dividend Ex-Date - Current Ratio 3.37 EPS Y/Y TTM 54.60% Oper. Margin -10.34% RSI (14) 61.61 Volatility 2.50% 3.28%
Employees 3682 Debt/Eq 1.49 Sales Y/Y TTM 30.04% Profit Margin -5.97% Recom 2.31 Target Price 105.70
Option/Short Yes / Yes LT Debt/Eq 1.45 EPS Q/Q 36.27% Payout - Rel Volume 1.29 Prev Close 114.82
Sales Surprise 1.40% EPS Surprise 11.48% Sales Q/Q 28.15% Earnings Feb 06 AMC Avg Volume 2.74M Price 117.16
SMA20 4.29% SMA50 10.17% SMA200 33.58% Trades
Volume 3,538,120 Change 2.04%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-17-25 Upgrade Citigroup
Neutral → Buy
$95 → $145
Jan-17-25 Initiated Cantor Fitzgerald
Neutral
$111
Jan-03-25 Reiterated RBC Capital Mkts
Outperform
$99 → $123
Jan-02-25 Upgrade Goldman
Sell → Buy
$77 → $140
Dec-17-24 Upgrade Stifel
Hold → Buy
$95 → $136
Dec-02-24 Upgrade Morgan Stanley
Equal-Weight → Overweight
Oct-08-24 Initiated Exane BNP Paribas
Underperform
$65
Jul-16-24 Initiated Wolfe Research
Peer Perform
Jul-08-24 Initiated Scotiabank
Sector Perform
$85
Jun-25-24 Upgrade UBS
Sell → Neutral
$76 → $82
May-07-24 Upgrade DZ Bank
Hold → Buy
$95
Feb-13-24 Downgrade DZ Bank
Buy → Hold
$110
Feb-09-24 Resumed Cantor Fitzgerald
Neutral
$100
Jan-18-24 Initiated Bernstein
Mkt Perform
$85
Jan-17-24 Initiated CapitalOne
Equal Weight
$83
Dec-15-23 Initiated Susquehanna
Neutral
$75
Nov-21-23 Upgrade Oppenheimer
Perform → Outperform
Sep-07-23 Initiated BofA Securities
Underperform
$52
Aug-07-23 Downgrade Guggenheim
Neutral → Sell
$50
Jun-05-23 Initiated UBS
Sell
$55
Show Previous Ratings
Jan-17-25 04:06PM
(Investor's Business Daily)
03:23PM
(Investor's Business Daily)
01:20PM
11:41AM
09:45AM
06:00PM
Loading…
Jan-16-25 06:00PM
Jan-14-25 04:01AM
Jan-13-25 09:00AM
Jan-11-25 05:37AM
Jan-09-25 05:50PM
04:15PM
09:50AM
Jan-08-25 04:01AM
Jan-07-25 10:34AM
Jan-06-25 10:07PM
06:00PM
Loading…
06:00PM
Jan-03-25 12:16PM
Jan-02-25 03:54PM
01:33PM
01:30PM
01:23PM
10:57AM
10:28AM
(Investor's Business Daily)
07:23AM
06:00AM
04:41AM
Jan-01-25 09:45AM
Dec-31-24 05:50PM
Dec-30-24 06:00PM
09:03AM
09:00AM
Loading…
09:00AM
Dec-25-24 07:37PM
Dec-24-24 05:50PM
Dec-23-24 06:00PM
Dec-20-24 10:59AM
Dec-19-24 04:15PM
11:43AM
09:00AM
Dec-17-24 04:00PM
11:51AM
09:00AM
Dec-15-24 05:12AM
Dec-14-24 06:31AM
Dec-13-24 02:51PM
(Investor's Business Daily)
10:42AM
Dec-11-24 12:15PM
06:53AM
Dec-10-24 12:08PM
Dec-09-24 03:48PM
(Investor's Business Daily)
10:00AM
Dec-06-24 06:49PM
09:00AM
Dec-04-24 09:00AM
08:00AM
(Investor's Business Daily)
Dec-03-24 02:00PM
Dec-02-24 02:37PM
02:02PM
01:38PM
10:38AM
10:02AM
Nov-29-24 04:48AM
Nov-25-24 09:00AM
Nov-22-24 06:30AM
04:45AM
Nov-21-24 04:29PM
(Investor's Business Daily) +8.05%
01:43PM
Nov-20-24 09:00AM
Nov-19-24 04:24PM
(Investor's Business Daily)
Nov-18-24 04:20PM
Nov-15-24 07:15AM
Nov-14-24 09:50AM
Nov-13-24 01:13PM
09:45AM
Nov-12-24 09:00AM
07:19AM
Nov-09-24 07:41AM
Nov-08-24 06:33PM
03:47PM
01:22PM
09:52AM
09:01AM
08:10AM
(Thomson Reuters StreetEvents)
07:53AM
02:35AM
12:03AM
Nov-07-24 08:45PM
07:35PM
06:27PM
(Associated Press Finance)
05:01PM
04:28PM
04:15PM
Nov-06-24 12:49PM
02:14AM
Oct-29-24 05:50PM
09:00AM
Oct-24-24 03:31AM
Oct-23-24 05:50PM
Oct-22-24 04:42PM
Oct-21-24 06:00PM
Oct-18-24 09:50AM
Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. It offers various products for performance and reliability, video streaming and delivery, advanced security, insights, Cloudflare for developers, domain registration, and Cloudflare marketplace. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
THOMAS J SEIFERT Officer Jan 17 '25 Proposed Sale 114.82 33,864 3,888,264 Jan 17 04:19 PM Prince Matthew CEO & Chair of the Board Jan 07 '25 Sale 114.72 52,384 6,009,539 10,762 Jan 08 08:41 PM Prince Matthew CEO & Chair of the Board Jan 06 '25 Sale 113.98 52,384 5,970,937 10,762 Jan 08 08:41 PM Prince Matthew CEO & Chair of the Board Jan 08 '25 Sale 113.73 52,384 5,957,673 10,762 Jan 08 08:41 PM SEIFERT THOMAS J Chief Financial Officer Jan 03 '25 Sale 113.81 15,000 1,707,161 252,869 Jan 06 04:59 PM Kramer Douglas James Chief Legal Officer Jan 02 '25 Sale 112.45 9,000 1,012,072 175,688 Jan 06 04:42 PM THOMAS J SEIFERT Officer Jan 03 '25 Proposed Sale 112.54 15,000 1,688,100 Jan 03 04:18 PM DOUGLAS KRAMER Officer Jan 02 '25 Proposed Sale 112.45 9,000 1,012,072 Jan 02 04:05 PM Prince Matthew CEO & Chair of the Board Dec 18 '24 Sale 113.00 52,384 5,919,416 10,762 Dec 20 08:42 PM Prince Matthew CEO & Chair of the Board Dec 20 '24 Sale 111.90 52,384 5,861,572 10,762 Dec 20 08:42 PM Prince Matthew CEO & Chair of the Board Dec 19 '24 Sale 108.72 52,384 5,695,092 10,762 Dec 20 08:42 PM SEIFERT THOMAS J Chief Financial Officer Dec 18 '24 Sale 112.72 15,000 1,690,860 252,869 Dec 19 05:19 PM THOMAS J SEIFERT Officer Dec 18 '24 Proposed Sale 117.56 15,000 1,763,400 Dec 18 04:25 PM Zatlyn Michelle President and COO Dec 12 '24 Sale 113.16 25,640 2,901,548 0 Dec 12 08:46 PM Zatlyn Michelle President and COO Dec 11 '24 Sale 112.69 25,640 2,889,457 0 Dec 12 08:46 PM Zatlyn Michelle President and COO Dec 10 '24 Sale 112.68 25,640 2,889,049 0 Dec 12 08:46 PM SEIFERT THOMAS J Chief Financial Officer Dec 04 '24 Sale 109.90 15,000 1,648,496 252,869 Dec 05 05:25 PM THOMAS J SEIFERT Officer Dec 04 '24 Proposed Sale 104.91 15,000 1,573,650 Dec 04 04:41 PM Kramer Douglas James Chief Legal Officer Dec 02 '24 Sale 105.57 3,000 316,710 175,688 Dec 03 04:29 PM DOUGLAS KRAMER Officer Dec 02 '24 Proposed Sale 105.57 3,000 316,710 Dec 02 04:05 PM Zatlyn Michelle President and COO Nov 25 '24 Sale 105.30 35,118 3,697,890 0 Nov 27 07:23 PM Zatlyn Michelle President and COO Nov 26 '24 Sale 104.39 25,640 2,676,675 0 Nov 27 07:23 PM Zatlyn Michelle President and COO Nov 27 '24 Sale 100.44 25,640 2,575,257 0 Nov 27 07:23 PM Michelle Zatlyn Officer Nov 25 '24 Proposed Sale 103.73 240,238 24,919,888 Nov 25 05:08 PM Kramer Douglas James Chief Legal Officer Nov 21 '24 Sale 100.00 6,000 600,000 175,688 Nov 21 04:17 PM DOUGLAS KRAMER Officer Nov 21 '24 Proposed Sale 100.00 6,000 600,000 Nov 21 04:05 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Nov 19 '24 Sale 95.03 28,635 2,721,044 252,869 Nov 19 07:14 PM Riley Janel CHIEF ACCOUNTING OFFICER Nov 18 '24 Sale 90.08 3,495 314,847 73,130 Nov 19 04:46 PM THOMAS J SEIFERT Officer Nov 19 '24 Proposed Sale 92.29 28,635 2,642,724 Nov 19 04:22 PM Prince Matthew CEO & Chair of the Board Nov 13 '24 Sale 95.59 52,384 5,007,175 0 Nov 15 07:59 PM Prince Matthew CEO & Chair of the Board Nov 14 '24 Sale 92.31 52,384 4,835,608 0 Nov 15 07:59 PM Prince Matthew CEO & Chair of the Board Nov 15 '24 Sale 89.06 52,384 4,665,521 0 Nov 15 07:59 PM Matthew Prince Officer Nov 13 '24 Proposed Sale 94.16 471,456 44,392,297 Nov 13 06:27 PM Eitel Maria S Director Nov 01 '24 Sale 88.00 6,875 605,033 5,927 Nov 04 07:16 PM Kramer Douglas James Chief Legal Officer Nov 01 '24 Sale 88.60 3,000 265,800 185,386 Nov 04 05:23 PM SEIFERT THOMAS J Chief Financial Officer Nov 04 '24 Sale 86.79 15,000 1,301,835 281,403 Nov 04 05:21 PM THOMAS J SEIFERT Officer Nov 04 '24 Proposed Sale 87.55 15,000 1,313,250 Nov 04 04:25 PM MARIA EITEL Director Nov 01 '24 Proposed Sale 88.00 6,875 605,033 Nov 01 04:42 PM DOUGLAS KRAMER Officer Nov 01 '24 Proposed Sale 88.60 3,000 265,800 Nov 01 04:37 PM SEIFERT THOMAS J Chief Financial Officer Oct 18 '24 Sale 90.88 15,000 1,363,158 281,403 Oct 21 04:50 PM THOMAS J SEIFERT Officer Oct 18 '24 Proposed Sale 90.40 15,000 1,356,000 Oct 18 04:19 PM Prince Matthew CEO & Chair of the Board Oct 15 '24 Sale 93.95 52,384 4,921,495 10,761 Oct 17 06:35 PM Prince Matthew CEO & Chair of the Board Oct 16 '24 Sale 91.93 52,384 4,815,583 10,761 Oct 17 06:35 PM Prince Matthew CEO & Chair of the Board Oct 17 '24 Sale 90.92 52,384 4,763,010 10,761 Oct 17 06:35 PM Zatlyn Michelle President and COO Oct 07 '24 Sale 81.60 64,100 5,230,592 0 Oct 09 07:48 PM Zatlyn Michelle President and COO Oct 09 '24 Sale 82.60 25,640 2,117,963 0 Oct 09 07:48 PM Zatlyn Michelle President and COO Oct 08 '24 Sale 80.44 25,640 2,062,427 0 Oct 09 07:48 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Oct 03 '24 Sale 79.19 15,000 1,187,865 281,403 Oct 04 05:29 PM THOMAS J SEIFERT Officer Oct 03 '24 Proposed Sale 79.34 15,000 1,190,100 Oct 03 04:27 PM Kramer Douglas James Chief Legal Officer Oct 02 '24 Sale 78.87 3,000 236,610 185,386 Oct 03 04:15 PM DOUGLAS KRAMER Officer Oct 02 '24 Proposed Sale 78.87 3,000 236,610 Oct 02 04:14 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Sep 18 '24 Sale 78.36 15,000 1,175,378 281,403 Sep 19 05:13 PM THOMAS J SEIFERT Officer Sep 18 '24 Proposed Sale 79.11 15,000 1,186,650 Sep 18 04:45 PM Zatlyn Michelle President and COO Sep 09 '24 Sale 77.13 12,820 988,780 0 Sep 11 07:55 PM Zatlyn Michelle President and COO Sep 11 '24 Sale 76.14 12,820 976,168 0 Sep 11 07:55 PM Zatlyn Michelle President and COO Sep 10 '24 Sale 75.63 12,820 969,517 0 Sep 11 07:55 PM Prince Matthew CEO & Chair of the Board Sep 05 '24 Sale 78.51 52,384 4,112,554 10,761 Sep 06 09:03 PM Prince Matthew CEO & Chair of the Board Sep 04 '24 Sale 78.06 52,384 4,089,133 10,761 Sep 06 09:03 PM Prince Matthew CEO & Chair of the Board Sep 06 '24 Sale 76.55 52,384 4,009,768 10,761 Sep 06 09:03 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Sep 04 '24 Sale 78.05 15,000 1,170,818 281,403 Sep 05 04:35 PM Kramer Douglas James CHIEF LEGAL OFFICER Sep 03 '24 Sale 81.53 3,000 244,590 185,386 Sep 04 04:26 PM THOMAS J SEIFERT Officer Sep 04 '24 Proposed Sale 78.11 15,000 1,171,650 Sep 04 04:14 PM DOUGLAS KRAMER Officer Sep 03 '24 Proposed Sale 81.53 3,000 244,590 Sep 03 04:15 PM Zatlyn Michelle President and COO Aug 20 '24 Sale 83.74 35,117 2,940,717 0 Aug 22 07:23 PM Zatlyn Michelle President and COO Aug 22 '24 Sale 81.91 25,640 2,100,243 0 Aug 22 07:23 PM Zatlyn Michelle President and COO Aug 21 '24 Sale 81.74 25,640 2,095,826 0 Aug 22 07:23 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Aug 20 '24 Sale 82.84 28,636 2,372,117 281,403 Aug 22 04:12 PM Michelle Zatlyn Officer Aug 20 '24 Proposed Sale 82.38 240,237 19,790,724 Aug 20 04:46 PM THOMAS J SEIFERT Officer Aug 20 '24 Proposed Sale 84.07 28,636 2,407,429 Aug 20 04:29 PM Riley Janel CHIEF ACCOUNTING OFFICER May 29 '24 Sale 73.47 17,938 1,317,982 87,270 Aug 16 05:19 PM Riley Janel CHIEF ACCOUNTING OFFICER Aug 16 '24 Sale 81.65 3,495 285,375 80,183 Aug 16 05:19 PM Prince Matthew CEO & Chair of the Board Aug 07 '24 Sale 78.17 52,384 4,094,614 0 Aug 09 07:05 PM Prince Matthew CEO & Chair of the Board Aug 09 '24 Sale 77.86 52,384 4,078,387 0 Aug 09 07:05 PM Prince Matthew CEO & Chair of the Board Aug 08 '24 Sale 76.70 52,384 4,017,884 0 Aug 09 07:05 PM Matthew Prince Officer Aug 07 '24 Proposed Sale 76.37 471,456 36,005,095 Aug 07 05:12 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Aug 02 '24 Sale 78.71 15,000 1,180,714 309,937 Aug 05 05:30 PM THOMAS J SEIFERT Officer Aug 02 '24 Proposed Sale 74.40 15,000 1,116,000 Aug 02 04:21 PM Kramer Douglas James CHIEF LEGAL OFFICER Aug 01 '24 Sale 77.17 3,000 231,510 195,303 Aug 02 04:16 PM Eitel Maria S Director Aug 01 '24 Sale 77.68 6,875 534,016 12,802 Aug 02 04:07 PM DOUGLAS KRAMER Officer Aug 01 '24 Proposed Sale 77.17 3,000 231,510 Aug 01 04:25 PM MARIA EITEL Director Aug 01 '24 Proposed Sale 77.68 6,875 534,016 Aug 01 04:16 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Jul 18 '24 Sale 78.89 15,000 1,183,382 309,937 Jul 19 05:35 PM Prince Matthew CEO & Chair of the Board Jul 09 '24 Sale 82.96 52,384 4,345,580 8,742 Jul 11 07:09 PM Prince Matthew CEO & Chair of the Board Jul 11 '24 Sale 82.67 52,384 4,330,796 8,742 Jul 11 07:09 PM Prince Matthew CEO & Chair of the Board Jul 10 '24 Sale 81.36 52,384 4,262,027 8,742 Jul 11 07:09 PM Zatlyn Michelle President and COO Jul 01 '24 Sale 82.52 102,580 8,464,511 0 Jul 03 05:45 PM Zatlyn Michelle President and COO Jul 03 '24 Sale 85.28 25,640 2,186,550 0 Jul 03 05:45 PM Zatlyn Michelle President and COO Jul 02 '24 Sale 84.49 25,640 2,166,370 0 Jul 03 05:45 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Jul 03 '24 Sale 84.97 15,000 1,274,571 309,937 Jul 03 04:57 PM Kramer Douglas James CHIEF LEGAL OFFICER Jul 01 '24 Sale 82.65 3,000 247,950 195,303 Jul 02 04:28 PM Ledbetter Carl Director Jun 26 '24 Sale 79.89 8,030 641,500 1,084,364 Jun 26 06:04 PM SEIFERT THOMAS J CHIEF FINANCIAL OFFICER Jun 20 '24 Sale 78.47 15,000 1,176,991 309,937 Jun 24 04:18 PM Zatlyn Michelle President and COO Jun 20 '24 Sale 78.51 12,820 1,006,444 0 Jun 21 07:10 PM Zatlyn Michelle President and COO Jun 18 '24 Sale 77.54 12,820 994,120 0 Jun 21 07:10 PM Zatlyn Michelle President and COO Jun 21 '24 Sale 76.41 12,820 979,573 0 Jun 21 07:10 PM Ledbetter Carl Director Jun 20 '24 Sale 78.56 10,015 786,785 1,092,394 Jun 20 04:26 PM Prince Matthew CEO & Chair of the Board Jun 12 '24 Sale 75.07 52,384 3,932,231 8,742 Jun 13 08:08 PM Prince Matthew CEO & Chair of the Board Jun 13 '24 Sale 74.46 52,384 3,900,705 8,742 Jun 13 08:08 PM Prince Matthew CEO & Chair of the Board Jun 11 '24 Sale 72.04 52,384 3,773,618 8,742 Jun 13 08:08 PM Ledbetter Carl Director Jun 12 '24 Sale 74.48 7,986 594,781 1,102,409 Jun 13 04:13 PM
Index RUT P/E - EPS (ttm) -0.44 Insider Own 48.29% Shs Outstand 170.84M Perf Week 5.40%
Market Cap 502.84M Forward P/E - EPS next Y -0.49 Insider Trans 0.04% Shs Float 88.75M Perf Month -10.12%
Income -82.94M PEG - EPS next Q -0.11 Inst Own 52.21% Short Float 15.17% Perf Quarter -21.66%
Sales 0.00M P/S - EPS this Y -39.77% Inst Trans 16.34% Short Ratio 9.29 Perf Half Y -37.79%
Book/sh 1.17 P/B 2.51 EPS next Y -5.42% ROA -39.41% Short Interest 13.47M Perf Year -33.56%
Cash/sh 1.28 P/C 2.29 EPS next 5Y - ROE -47.95% 52W Range 2.60 - 5.70 Perf YTD -4.56%
Dividend Est. - P/FCF - EPS past 5Y 29.09% ROI -36.71% 52W High -48.60% Beta 0.65
Dividend TTM - Quick Ratio 17.70 Sales past 5Y -25.00% Gross Margin - 52W Low 12.69% ATR (14) 0.20
Dividend Ex-Date - Current Ratio 17.70 EPS Y/Y TTM -39.95% Oper. Margin - RSI (14) 43.56 Volatility 8.66% 6.01%
Employees 37 Debt/Eq 0.13 Sales Y/Y TTM - Profit Margin - Recom 1.25 Target Price 9.56
Option/Short Yes / Yes LT Debt/Eq 0.13 EPS Q/Q -13.37% Payout - Rel Volume 0.68 Prev Close 2.91
Sales Surprise - EPS Surprise -1.29% Sales Q/Q - Earnings Nov 12 BMO Avg Volume 1.45M Price 2.93
SMA20 -4.06% SMA50 -10.77% SMA200 -27.58% Trades
Volume 985,378 Change 0.69%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-20-24 Initiated Wells Fargo
Overweight
$8
Nov-13-24 Downgrade Evercore ISI
Outperform → In-line
$7 → $5
Feb-15-24 Initiated JMP Securities
Mkt Outperform
$8
Nov-07-23 Initiated Guggenheim
Buy
$7
May-16-23 Upgrade Jefferies
Hold → Buy
$2 → $4
Mar-31-23 Downgrade Jefferies
Buy → Hold
$2
Mar-16-21 Initiated Piper Sandler
Overweight
$7
Mar-15-21 Initiated Oppenheimer
Outperform
$4
Jun-13-19 Reiterated H.C. Wainwright
Buy
$22 → $6
Jun-13-19 Downgrade Ladenburg Thalmann
Buy → Neutral
$21 → $3
Jun-13-19 Downgrade JMP Securities
Mkt Outperform → Mkt Perform
Aug-13-18 Resumed ROTH Capital
Neutral
$12
Jan-03-18 Initiated Ladenburg Thalmann
Buy
$35
Sep-27-17 Resumed ROTH Capital
Buy
$40
Sep-22-17 Initiated Jefferies
Buy
$20
Sep-11-17 Initiated JMP Securities
Mkt Outperform
$20
Show Previous Ratings
Dec-23-24 04:05PM
Dec-18-24 04:05PM
(Business Wire) -6.21%
+6.95%
Dec-17-24 04:05PM
Nov-22-24 04:05PM
08:05AM
01:21PM
Loading…
Nov-13-24 01:21PM
08:05AM
Nov-12-24 08:05AM
Nov-04-24 04:05PM
Oct-22-24 08:05AM
Oct-18-24 04:05PM
Oct-01-24 08:05AM
Sep-27-24 04:05PM
08:05AM
Sep-24-24 08:05AM
08:05AM
Loading…
Sep-23-24 08:05AM
Sep-08-24 06:45AM
Sep-06-24 04:05PM
Sep-03-24 04:05PM
Sep-01-24 10:26PM
Aug-29-24 08:41PM
Aug-16-24 04:05PM
Aug-15-24 08:05AM
Aug-12-24 04:05PM
Jun-29-24 08:35PM
06:30PM
Jun-28-24 08:50AM
Jun-26-24 07:41AM
06:30AM
Jun-25-24 08:05PM
09:00AM
Loading…
Jun-19-24 09:00AM
Jun-11-24 06:00AM
May-29-24 08:05AM
May-21-24 08:20AM
May-19-24 12:15PM
May-16-24 04:05PM
May-09-24 10:55PM
04:05PM
May-07-24 04:05PM
(Business Wire) +6.26%
-5.13%
Apr-08-24 08:05AM
Mar-22-24 04:05PM
Mar-07-24 10:54PM
04:05PM
Mar-06-24 04:05PM
Feb-02-24 08:05AM
Jan-31-24 08:05AM
Dec-30-23 03:01PM
Dec-21-23 08:05AM
Dec-20-23 08:05AM
Dec-15-23 04:05PM
Nov-21-23 08:05AM
Nov-09-23 04:05PM
Nov-08-23 04:05PM
Oct-06-23 04:05PM
Sep-27-23 07:29PM
Sep-17-23 10:54AM
Sep-12-23 09:12AM
Sep-05-23 04:05PM
Aug-10-23 04:05PM
Aug-04-23 04:05PM
Jul-13-23 07:00AM
Jun-26-23 04:05PM
08:05AM
Jun-02-23 08:05AM
May-28-23 08:26AM
May-16-23 12:32PM
May-15-23 08:05AM
May-05-23 04:05PM
Apr-03-23 07:33AM
Mar-31-23 04:05PM
Mar-30-23 04:05PM
Mar-20-23 06:35AM
Mar-17-23 06:47AM
Mar-16-23 06:51AM
Mar-15-23 06:44AM
Mar-13-23 06:32AM
Mar-10-23 07:04AM
Mar-09-23 06:33AM
Mar-08-23 06:30AM
Mar-07-23 06:34AM
Mar-06-23 04:05PM
07:22AM
Mar-03-23 06:38AM
Mar-02-23 06:44AM
Mar-01-23 06:01AM
Feb-28-23 04:05PM
06:43AM
Feb-27-23 06:50AM
Feb-23-23 07:21AM
Feb-22-23 06:56AM
Feb-21-23 07:35AM
Feb-17-23 06:27AM
Feb-16-23 07:28AM
Feb-15-23 07:01AM
06:24AM
Feb-14-23 08:05AM
06:23AM
Feb-13-23 07:30AM
Feb-10-23 06:42AM
Feb-09-23 06:51AM
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lowrance David L Chief Financial Officer Dec 16 '24 Sale 3.33 25,000 83,278 381,005 Dec 16 05:59 PM Pauls Matthew CHIEF EXECUTIVE OFFICER Dec 16 '24 Sale 3.31 54,702 180,828 1,536,379 Dec 16 05:56 PM Hawkins Richard J Director Dec 16 '24 Sale 3.32 8,000 26,569 67,241 Dec 16 05:53 PM Pauls Matthew Director Dec 16 '24 Proposed Sale 3.31 54,702 180,800 Dec 16 05:13 PM Hawkins Richard J Director Dec 16 '24 Proposed Sale 3.29 8,000 26,300 Dec 16 03:15 PM Lowrance David L Officer Dec 16 '24 Proposed Sale 3.30 25,000 82,500 Dec 16 03:08 PM McCracken Joseph S Director Nov 19 '24 Buy 2.95 20,000 59,072 210,837 Nov 20 07:55 AM RAMSAY DAVID A Director Nov 18 '24 Buy 2.88 100,000 287,600 2,323,642 Nov 18 12:33 PM
Index - P/E - EPS (ttm) -0.62 Insider Own 11.50% Shs Outstand 64.48M Perf Week -1.89%
Market Cap 16.77M Forward P/E - EPS next Y - Insider Trans -23.45% Shs Float 57.07M Perf Month 8.38%
Income -39.74M PEG - EPS next Q - Inst Own 42.04% Short Float 3.81% Perf Quarter 65.71%
Sales 0.01M P/S 1677.00 EPS this Y - Inst Trans 34.28% Short Ratio 0.11 Perf Half Y -12.22%
Book/sh 0.18 P/B 1.47 EPS next Y - ROA -115.34% Short Interest 2.17M Perf Year -90.94%
Cash/sh 0.22 P/C 1.17 EPS next 5Y - ROE -137.20% 52W Range 0.14 - 3.53 Perf YTD 4.42%
Dividend Est. - P/FCF - EPS past 5Y 13.11% ROI -349.28% 52W High -92.63% Beta 1.82
Dividend TTM - Quick Ratio 3.62 Sales past 5Y -67.20% Gross Margin -484.71% 52W Low 84.92% ATR (14) 0.03
Dividend Ex-Date - Current Ratio 3.62 EPS Y/Y TTM 3.16% Oper. Margin -367849.25% RSI (14) 48.40 Volatility 8.04% 12.58%
Employees 35 Debt/Eq 0.02 Sales Y/Y TTM -86.67% Profit Margin -397354.06% Recom 3.00 Target Price 0.50
Option/Short Yes / Yes LT Debt/Eq 0.00 EPS Q/Q -6.57% Payout - Rel Volume 0.01 Prev Close 0.25
Sales Surprise - EPS Surprise -6.25% Sales Q/Q - Earnings Aug 01 Avg Volume 20.24M Price 0.26
SMA20 3.60% SMA50 -13.52% SMA200 -44.24% Trades
Volume 224,670 Change 3.09%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-26-24 Downgrade TD Cowen
Buy → Hold
Dec-22-23 Initiated CapitalOne
Overweight
$12
Nov-12-21 Upgrade Jefferies
Hold → Buy
$3 → $4
Nov-14-19 Initiated ROTH Capital
Buy
$12
Aug-05-19 Downgrade SunTrust
Buy → Hold
$23 → $5
Aug-05-19 Downgrade Piper Jaffray
Overweight → Neutral
$20 → $6
Aug-05-19 Downgrade Jefferies
Buy → Hold
Apr-12-19 Initiated Piper Jaffray
Overweight
$20
Dec-18-18 Initiated H.C. Wainwright
Buy
$24
Jul-26-16 Initiated SunTrust
Buy
Mar-17-15 Reiterated Stifel
Buy
$13 → $14
Show Previous Ratings
Jan-14-25 09:34AM
Nov-13-24 05:15PM
(Associated Press Finance)
Nov-12-24 08:00AM
Nov-06-24 07:00AM
Oct-30-24 08:31AM
07:00AM
Loading…
Oct-29-24 07:00AM
06:30AM
Jul-25-24 09:00AM
Jul-22-24 07:00AM
Jun-26-24 07:41AM
Jun-25-24 07:37AM
Jun-04-24 07:00AM
May-29-24 04:01PM
May-28-24 04:05AM
May-09-24 10:58PM
07:19PM
Loading…
07:19PM
(Associated Press Finance)
May-08-24 07:42AM
May-07-24 05:21AM
May-06-24 03:53PM
12:45PM
08:40AM
07:52AM
07:28AM
06:00AM
Apr-25-24 07:00AM
Mar-28-24 10:12AM
02:10AM
(Thomson Reuters StreetEvents)
Mar-27-24 11:53AM
10:31AM
07:14AM
(Associated Press Finance)
07:00AM
Loading…
07:00AM
Mar-21-24 08:50AM
Mar-13-24 07:00AM
Feb-26-24 07:00AM
Feb-12-24 07:00AM
Jan-04-24 07:00AM
Jan-03-24 07:00AM
Dec-10-23 12:00PM
Nov-09-23 07:00AM
Nov-05-23 08:51AM
Nov-04-23 01:48AM
(Thomson Reuters StreetEvents)
Nov-03-23 10:33AM
07:07AM
(Associated Press Finance)
07:00AM
Oct-23-23 08:30AM
Oct-20-23 07:00AM
Sep-06-23 07:00AM
Sep-05-23 07:00AM
Aug-17-23 07:00AM
Aug-02-23 07:17AM
(Associated Press Finance)
07:00AM
Jul-19-23 07:00AM
Jul-13-23 09:29AM
Jun-26-23 08:00AM
Jun-15-23 08:00AM
Jun-12-23 11:13AM
May-31-23 07:00AM
May-16-23 10:37AM
May-03-23 10:17PM
(Thomson Reuters StreetEvents)
+7.35%
07:23AM
07:00AM
Apr-26-23 07:00AM
Apr-19-23 10:20AM
Apr-05-23 01:45PM
Mar-31-23 04:30AM
Mar-29-23 07:00AM
Mar-21-23 06:23AM
Mar-20-23 06:35AM
Mar-17-23 06:47AM
Mar-16-23 07:00AM
06:51AM
Mar-15-23 06:44AM
Mar-13-23 06:32AM
Mar-10-23 07:04AM
Mar-09-23 06:33AM
Mar-08-23 06:30AM
Mar-07-23 06:34AM
Mar-06-23 07:22AM
Mar-03-23 06:38AM
Mar-02-23 06:44AM
Mar-01-23 07:00AM
06:01AM
06:01AM
Feb-28-23 06:43AM
Feb-27-23 06:50AM
Feb-24-23 07:17AM
07:17AM
Feb-16-23 08:00AM
Feb-15-23 08:00AM
Feb-14-23 06:23AM
Feb-06-23 07:00AM
Jan-22-23 07:30AM
07:24AM
Dec-30-22 07:17AM
Dec-28-22 06:58AM
Dec-26-22 07:14AM
Dec-19-22 09:40AM
Dec-12-22 07:00AM
Dec-02-22 01:18PM
09:40AM
GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Invus Public Equities, L.P. 10% Owner Aug 08 '24 Sale 0.19 260,873 50,009 6,317,565 Aug 09 04:30 PM Invus Public Equities, L.P. 10% Owner Aug 07 '24 Sale 0.18 61,488 11,197 6,578,438 Aug 09 04:30 PM Invus Public Equities, L.P. 10% Owner Aug 05 '24 Sale 0.19 164,523 30,996 6,695,658 Aug 07 04:30 PM Invus Public Equities, L.P. 10% Owner Aug 06 '24 Sale 0.18 55,732 10,188 6,639,926 Aug 07 04:30 PM Invus Public Equities, L.P. 10% Owner Aug 02 '24 Sale 0.20 286,200 57,354 6,860,181 Aug 05 04:53 PM Invus Public Equities, L.P. 10% Owner Aug 01 '24 Sale 0.22 63,564 13,743 7,146,381 Aug 05 04:53 PM Invus Public Equities, L.P. 10% Owner Jul 30 '24 Sale 0.22 756,835 167,185 7,209,945 Jul 30 05:16 PM Invus Public Equities, L.P. 10% Owner Jul 29 '24 Sale 0.24 363,949 85,637 7,966,780 Jul 30 05:16 PM Invus Public Equities, L.P. 10% Owner Jul 26 '24 Sale 0.24 258,335 62,440 8,330,729 Jul 30 05:16 PM Rock Edwin Chief Medical Officer Jun 20 '24 Buy 0.25 190,000 48,108 565,403 Jun 24 04:29 PM Rock Edwin Chief Medical Officer Jun 21 '24 Buy 0.27 115,000 30,716 680,403 Jun 24 04:29 PM Hahn Brian M. SVP Finance, CFO Jun 18 '24 Buy 0.25 17,500 4,335 70,643 Jun 20 04:15 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
